subconjunctival bevacizumab

DRUG2 trials

Sponsors

Grewal Eye Institute, Abe Adeola

Conditions

Eye DiseasesGlaucoma

Phase 3

Safety and efficacy of subconjunctival bevacizumab compared with placebo in the management of acquired cornea opacity with neovascularization.

Active, not recruitingPACTR202509763211872

Abe AdeolaEye Diseases

Start: 2025-10-01Target: 64Updated: 2026-01-27

Phase 4

Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

Grewal Eye InstituteGlaucoma

Start: 2007-05-31End: 2007-12-31Target: 40Updated: 2007-06-04